Evidence map›Paper›PMID 36838986›Full record

ReviewMolecules (Basel, Switzerland)2023

Synthesis and Application Dichalcogenides as Radical Reagents with Photochemical Technology.

Cairong Wang, Yan Zhang, Kai Sun, Tingting Yu, Fei Liu, Xin Wang

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. NiH-Catalyzed Enantio- and Regioselective Hydroselenylation of Unactivated Alkenes.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. [Tc(NO)ClMolecules (Basel, Switzerland) · 2025
    Article
  4. Photo-induced carboxylation of C(spNature communications · 2024
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Cairong WangDepartment of Chemistry, Changzhi University, Changzhi 046011, China.
Yan ZhangCollege of Chemistry and Chemical Engineering, Yantai University, Yantai 264005, China.
Kai SunCollege of Chemistry and Chemical Engineering, Yantai University, Yantai 264005, China.ORCID 0000-0002-0041-6044
Tingting YuDepartment of Chemistry, Changzhi University, Changzhi 046011, China.
Fei LiuCollege of Chemistry and Chemical Engineering, Yantai University, Yantai 264005, China.
Xin WangCollege of Chemistry and Chemical Engineering, Yantai University, Yantai 264005, China.

Funding

Higher Education Reform and Innovation Project of Shanxi Province J2021690National Natural Science Foundation of China 21801007
6 · The paper itself

Abstract

Dichalcogenides (disulfides and diselenides), as reactants for organic transformations, are important and widely used because of their potential to react with nucleophiles, electrophilic reagents, and radical precursors. In recent years, in combination with photochemical technology, the application of dichalcogenides as stable radical reagents has opened up a new route to the synthesis of various sulfur- and selenium-containing compounds. In this paper, synthetic strategies for disulfides and diselenides and their applications with photochemical technology are reviewed: (i) Cyclization of dichalcogenides with alkenes and alkynes; (ii) direct selenylation/sulfuration of C-H/C-C/C-N bonds; (iii) visible-light-enabled seleno- and sulfur-bifunctionalization of alkenes/alkynes; and (iv) Direct construction of the C(sp)-S bond. In addition, the scopes, limitations, and mechanisms of some reactions are also described.

Indexed as

Selenium CompoundsSulfurAlkenesAlkynesDisulfidesTechnologyAlkenesAlkynesDisulfidesSelenium CompoundsSulfurdiselenidedisulfidefree radicalsvisible light

Identifiers

PMID36838986
PMCPMC9963440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.